Brief: Vaxil Bio Announces Collaboration Agreement With The Tel Aviv Sourasky Medical Center
05/05/2020 14:19
May 5 (Reuters) - Vaxil Bio Ltd VXL.V :
* VAXIL ANNOUNCES COLLABORATION AGREEMENT WITH THE TEL AVIV
SOURASKY MEDICAL CENTER (ICHILOV HOSPITAL), ISRAEL’S LEADING
TERTIARY CARE FACILITY
* VAXIL BIO - AGREEMENT BETWEEN CO, TEL AVIV MEDICAL CENTER
TO
ADVANCE CO'S RESEARCH PROGRAM TO DEVELOP POTENTIAL PEPTIDE
VACCINE AGAINST COVID-19
Source text for Eikon: ID:nGNXk7dk7
Further company coverage: VXL.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vaxil Bio
See all newsBrief: Vaxil Announces Close Of Previously Announced Non-Brokered Private Placement
Brief: Vaxil Bio Says Proposed Reverse Takeover With Green Date Terminated
Brief: Vaxil Bio Enters Into Definitive Agreement With Green Data Centers for Reverse Take Over
Brief: Vaxil Bio To Continue Actively Explore Other Strategic Options
Brief: Vaxil Bio Enters Into Letter Of Intent With Copper Bullet Mines In Respect Of A Proposed Reverse Takeover